Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 144 participants.

Also called NCT05696444

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05696444
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05696444. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-14 (actual); primary completion 2024-10-10 (actual). Results posted on 2025-11-25.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
Condition
Bladder Cancer
Condition
Prostate Cancer
Condition
Kidney Cancer
Condition
Pelvic Tumor
Condition
Interstitial Cystitis
Condition
Congenital Abnormalities
Condition
End Stage Renal Disease
Condition
Renal Tumor
Condition
Kidney Injury
Intervention (Device)
RAS Prostatectomy
Intervention (Device)
RAS Cystectomy
Intervention (Device)
RAS Nephrectomy
Lead sponsor
Medtronic - MITG (class: industry)

Record details

Record id
cardio:ct-nct05696444
Content hash
53b61428095022b92bd0fac2fe1b302bc79818301c36fa18e91dbb9f33744193